Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07114744 · ClinicalTrials.gov registry record
Early Cochlear Implant Use
A clinical trial of Cochlear Implant Users, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT07114744 is a study of Cochlear Implant Users that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 25 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07114744, a study of Cochlear Implant Users, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This observational study will examine newly activated cochlear implant users and determine whether their abilities to discern simple sounds change and relate to improved speech perception. Take-home computers and test-equipment will be sent home, and subjects will complete approximately 25 test sessions over the first 3 months of cochlea implant use. Then, subjects will be tested 3 more times in the laboratory until 1 year-post activation. The primary objective is to determine and quantify how sounds change and speech perception improves over the course of early cochlear implant use.
Conditions Studied
Interventions
- OTHER Take home tests
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2025-06-11 |
| Est. Completion | 2027-07-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07114744
The ClinicalTrials.gov registry entry for NCT07114744 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cochlear Implant Users appearing as the primary indexed condition, and to 1 intervention - of which Take home tests is the first listed.
NCT07114744 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT07114744 about?
NCT07114744 is a clinical study titled "Early Cochlear Implant Use". This observational study will examine newly activated cochlear implant users and determine whether their abilities to discern simple sounds change and relate to improved speech perception. Take-home computers and test-equipment will be sent home, and subjects will complete approximately 25 test sess...
What is the current status of trial NCT07114744?
This trial is currently recruiting. The enrollment target is 25 participants. The study started on 2025-06-11. Estimated completion is 2027-07-01.
What conditions does trial NCT07114744 study?
This clinical trial studies the following conditions: Cochlear Implant Users.
What interventions are being tested in trial NCT07114744?
The interventions under investigation include: Take home tests (OTHER).
Who is sponsoring clinical trial NCT07114744?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07114744 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cochlear Implant Users
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.